Freedom Holding
FRHC
174.75
+0.89
+0.51%
Freedom Holding
US · FRHC
#1384 by market cap
Listed 1970
174.75
+0.89
+0.51%
Live - 5344 symbols - heartbeat 193s ago
· 2026-10-08 02:07
After-hours
174.75
0.00%
Overnight
173.78
-0.56%
- Market cap
- 11.15B
- P/E (TTM)i
- 72.21
- P/Bi
- 7.26
- EPSi
- 2.51
- Div yieldi
- 0.00%
- 52W posi
- 95%
Reader sentiment
Are you bullish or bearish on FRHC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.33, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +9.34% YoY
Margins
- Gross margin
- 54.56%
- Operating margin
- 31.82%
- Net margin
- 7.08%
Key ratios & quality
- Enterprise valuei
- 9.65B
- Altman Z-Scorei
- 1.33
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 74.29M | 83.39M | 346.88M | 689.79M | 799.14M | 1.65B | 2.00B | 2.19B |
| Gross profit | 68.05M | 63.98M | 200.51M | 503.15M | 570.89M | 1.17B | 1.06B | 1.18B |
| Selling & admin expenses | -- | -- | 22.63M | 55.99M | 100.33M | 216.17M | 375.62M | 439.95M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 23.42M | 38.30M | 177.87M | 444.65M | 441.44M | 930.35M | 623.41M | 689.07M |
| Pretax profit | 8.52M | 29.09M | 151.81M | 363.69M | 235.94M | 438.94M | 104.58M | 225.97M |
| Tax | 1.37M | 4.93M | 23.31M | 38.57M | 42.78M | 60.42M | 28.43M | 72.64M |
| Net profit | 7.15M | 22.13M | 150.28M | 220.93M | 205.59M | 378.52M | 76.16M | 153.33M |
| Basic EPS | 0 | 0 | 3 | 4 | 4 | 6 | 1 | 3 |
| Diluted EPS | 0.12 | 0.43 | 2.56 | 3.84 | 3.45 | 6.39 | 1.26 | 2.51 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 298.44M | 523.98M | 526.11M | 628.62M | 503.14M | 732.53M |
| Gross profit | 149.19M | 259.66M | 278.52M | 354.51M | 333.38M | 369.64M |
| Selling & admin expenses | 82.56M | 102.52M | 99.05M | 139.36M | 99.02M | 145.23M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -32.07M | 152.32M | 159.71M | 199.99M | 184.01M | 206.75M |
| Pretax profit | -163.83M | 47.48M | 60.49M | 93.95M | 31.02M | 40.83M |
| Tax | -13.10M | 10.12M | 21.77M | 17.71M | 23.04M | 9.17M |
| Net profit | -150.73M | 37.36M | 38.72M | 76.24M | 7.98M | 31.66M |
| Basic EPS | -3 | 1 | 1 | 1 | 0 | 1 |
| Diluted EPS | -2.55 | 0.61 | 0.63 | 1.25 | 0.13 | 0.52 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 336.04M | 425.28M | 2.06B | 3.19B | 4.96B | 8.08B | 9.50B | 12.18B |
| Cash & ST investments | 217.91M | 226.19M | 755.56M | 1.55B | 3.23B | 4.45B | 3.59B | 3.88B |
| Inventory | -- | -- | -- | -- | -- | 2.27M | 6.40M | 17.62M |
| Total assets | 350.91M | 453.52M | 2.10B | 3.23B | 5.08B | 8.30B | 9.92B | 13.16B |
| Total current liabilities | 190.75M | 227.83M | 1.76B | 2.51B | 3.64B | 6.03B | 7.22B | 9.01B |
| Short-term debt | 73.62M | 48.20M | 374.72M | 840.22M | 1.52B | 2.76B | 1.42B | 1.02B |
| Long-term debt | 32.55M | 72.30M | 34.72M | 37.93M | 60.03M | 276.72M | 494.41M | 1.36B |
| Total liabilities | 233,314,000.00 | 324,486,000.00 | 1,824,651,000.00 | 2,683,739,000.00 | 4,313,822,000.00 | 7,134,972,000.00 | 8,690,553,000.00 | 11,665,960,000.00 |
| Total equity | 117.60M | 129.04M | 275.67M | 546.61M | 770.74M | 1.17B | 1.22B | 1.49B |
| Retained earnings | 41.50M | 66.34M | 208.63M | 441.92M | 647.06M | 998.74M | 1.08B | 1.23B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 9.50B | 8.48B | 9.08B | 10.81B | 12.18B | 12.58B |
| Cash & ST investments | 3.59B | 2.71B | 2.47B | 3.14B | 3.88B | 5.01B |
| Inventory | 6.40M | -- | -- | -- | 17.62M | -- |
| Total assets | 9.92B | 9.69B | 10.35B | 12.38B | 13.16B | 14.05B |
| Total current liabilities | 7.22B | 6.67B | 7.23B | 8.60B | 9.01B | 9.08B |
| Short-term debt | 1.42B | 1.07B | 806.34M | 1.06B | 1.02B | 1.25B |
| Long-term debt | 494.41M | 670.13M | 742.77M | 1.08B | 1.36B | 1.47B |
| Total liabilities | 8,690,553,000.00 | 8,460,694,000.00 | 9,128,547,000.00 | 10,981,963,000.00 | 11,665,960,000.00 | 12,511,607,000.00 |
| Total equity | 1.22B | 1.23B | 1.22B | 1.39B | 1.49B | 1.54B |
| Retained earnings | 1.08B | 1.12B | 1.15B | 1.23B | 1.23B | 1.26B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 58.48M | 82.62M | 529.40M | -406.37M | -951.68M | -1.06B | 1.68B | 185.22M |
| Depreciation & amortization | 2.03M | 1.11M | 2.69M | 3.42M | 5.14M | 14.60M | 17.16M | 34.56M |
| Free cash flow | 53.49M | 80.63M | 527.88M | -411.99M | -990.23M | -1.11B | 1.59B | -36.92M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | 455.00K | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 88.42M | 187.18M | 1.22B | 1.23B | 1.03B | 1.01B | 1.64B | 2.21B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.34B | 480.83M | 535.28M | 717.78M | -1.55B | -341.62M |
| Depreciation & amortization | 4.45M | 6.11M | 6.27M | 8.32M | 13.86M | 9.88M |
| Free cash flow | 1.30B | 450.04M | 456.35M | 651.73M | -1.60B | -436.57M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | 0 | -- | -- | -- | 300.00M |
| Ending cash balance | 1.64B | 1.67B | 1.95B | 3.51B | 2.21B | 2.82B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 6.14 | 19.96 | 69.65 | 55.04 | 31.76 | 38.70 | 7.12 | 11.34 |
| ROA %i | 2.10 | 6.18 | 11.51 | 8.82 | 5.12 | 5.61 | 0.93 | 1.33 |
| ROIC %i | 7.60 | 14.12 | 31.25 | 26.00 | 19.84 | 24.39 | 13.12 | 13.69 |
| 5-year avg ROE %i | -- | -278.28 | 29.78 | 35.02 | 36.93 | 43.57 | 40.86 | 28.47 |
| EBIT margin %i | 31.18 | 33.25 | 56.84 | 55.39 | 55.91 | 57.27 | 31.91 | 33.02 |
| FCF / sales %i | 72.00 | 32.52 | 159.16 | -- | -- | -- | 77.98 | -- |
| Current ratioi | 1.76 | 1.87 | 1.17 | 1.27 | 1.36 | 1.34 | 1.32 | 1.35 |
| Quick ratioi | 1.55 | 1.54 | 0.46 | 0.72 | 1.23 | 1.25 | 1.19 | 1.19 |
| Debt / assetsi | 30.25 | 29.74 | 19.72 | 27.42 | 31.62 | 36.97 | 19.70 | 18.48 |
| LT debt / equityi | 27.68 | 66.01 | 14.26 | 8.21 | 11.62 | 26.86 | 43.69 | 94.46 |
| Interest coveragei | 1.58 | 3.27 | 7.32 | 4.12 | 2.13 | 1.87 | 1.21 | 1.46 |
| Revenue CAGR (3Y) %i | -- | 62.72 | 81.77 | 110.19 | 112.10 | 67.75 | 42.29 | 39.61 |
| Net income CAGR (3Y) %i | -- | 58.08 | 101.85 | 216.92 | 102.14 | 36.32 | -30.53 | -9.25 |
| FCF CAGR (3Y) %i | -- | 158.09 | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 7.12 | 6.78 | 0.38 | 0.20 | 11.34 | 10.68 |
| ROA %i | 0.93 | 0.89 | 0.05 | 0.02 | 1.33 | 1.24 |
| ROIC %i | 13.12 | 12.64 | 10.43 | 9.51 | 13.69 | 14.18 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 31.91 | 29.12 | 25.95 | 25.22 | 33.02 | 32.58 |
| FCF / sales %i | 77.98 | 57.05 | 104.29 | 139.14 | -- | -- |
| Current ratioi | 1.32 | 1.27 | 1.26 | 1.26 | 1.35 | 1.38 |
| Quick ratioi | 1.19 | 1.11 | 1.07 | 0.95 | 1.19 | 1.22 |
| Debt / assetsi | 19.70 | 18.39 | 15.34 | 17.57 | 18.48 | 19.85 |
| LT debt / equityi | 43.69 | 57.68 | 64.00 | 80.24 | 94.46 | 99.90 |
| Interest coveragei | 1.21 | 1.22 | 1.09 | 1.08 | 1.46 | 1.40 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Brokerage is the largest reported line at 38.57% of revenue, across 4 reported segments.
- No single line clears half of revenue; Banking is next at 30.75%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Brokerage38.57%
Banking30.75%
Insurance20.59%
Other10.09%
Quote time 2026-10-08 02:07:33 · For reference only, not investment advice and not tailored to your situation.